Save the Date: June 25, 2025

Advancing Neuroscience: Breakthroughs in Biomarker Discovery and Preclinical Development for Neurological Diseases

  • days
  • Hours
  • Minutes
  • Seconds

You're Invited!

You are invited to a complimentary neuroscience symposium in South San Francisco, CA. Hosted by BioIVT, home to the Center for NeuroExcellence, this symposium will bring together leading researchers, drug developers, and industry professionals to explore cutting-edge advancements in neuroscience and biomarkers.

Featuring researchers from academia, industry, and BioIVT, this event will highlight breakthroughs in biomarker discovery and preclinical drug development in neurological diseases.

Target Audience:

  • Drug developers interested in the latest advancements in biomarkers for neurodegenerative diseases
  • Scientists and directors interested in overcoming challenges for CNS-targeting drugs
  • Lab scientists, managers, and directors in biotech/pharma working on drug development in CNS diseases

Attendees will learn:

  • The importance and application of biomarkers in neurodegenerative diseases, including how demographic factors influence biomarkers and the latest advances in blood biomarker tests.
  • The challenges of developing CNS drugs and crossing the blood-brain barrier, with a focus on the pivotal role of transporters.
  • The latest breakthroughs and innovative therapies in drug development for neurodegenerative diseases such as ALS and Alzheimer’s disease.
  • Cutting-edge research on Alzheimer’s disease, from uncovering key pathology drivers and biomarkers to advancing therapeutic innovation.

Registration is required to attend.

Agenda: June 25

Check-In, Coffee, & Networking

Arrival, registration, coffee, and networking with fellow neuroscience enthusiasts and experts.

Lunch

Abstract: Carboxylesterases (CES) represent an important pathway of drug metabolism. However, the striking differences

Coffee Break

Arrival, registration, coffee, and networking with fellow neuroscience enthusiasts and experts.

Panel Discussion

Hosted by: Tina Mueller with panelists Courtney Noah, Philip Verghese, Christian Cizek, Mark Warren, and Sheng Zhong

Happy Hour and Networking

Speaker: Dr. Tina Mueller, Scientific Advisor, ADMET Services, BioIVT

Abstract: There is renewed interest in developing psychedelics such as psilocybin, 

The Lighthouse Cafe

The event will be held at The Lighthouse Cafe & Conference Center: 685 Gateway Boulevard, South San Francisco, CA, 94080.

Resources

admetoxproducts-1

BioIVT has been the leading provider of ADME products for more than 25 years. In that time, we have isolated hepatocytes from several thousand human livers and continue to add several hundred new lots each year. 

admetoxservices-1

BioIVT provides ADME / DMPK services including consulting on ADME strategies, design and implementation of in vitro and in vivo studies, bioanalysis, analysis of study data, and report development.

adme-consulting

Learn more about ADME Consulting Services at BioIVT. Our experts help researchers optimize in vitro research programs and ensure data packages are ready for regulatory submissions.